The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care setting
Matthew Lewis, Patty Chondros, Cathrine Mihalopoulos, Yong Yi Lee, Jane M Gunn, Carol Harvey, John Furler, David Osborn, David Castle, Sandra Davidson, Mahesh Jayaram, Amanda Kenny, Mark R Nelson, Vera A Morgan, Stephen Harrap, Kylie McKenzie, Maria Potiriadis, Konstancja Densley, Victoria J Palmer
Contemporary Clinical Trials | ELSEVIER SCIENCE INC | Published : 2020
BACKGROUND: Cardiovascular disease (CVD) accounts for 40% of the excess mortality identified in people with severe mental illness (SMI). Modifiable CVD risk factors are higher and can be exacerbated by the cardiometabolic impact of psychotropic medications. People with SMI frequently attend primary care presenting a valuable opportunity for early identification, prevention and management of cardiovascular health. The ACCT Healthy Hearts Study will test a coproduced, nurse-led intervention delivered with general practitioners to reduce absolute CVD risk (ACVDR) at 12 months compared with an active control group. METHODS/DESIGN: ACCT is a two group (intervention/active control) individually ra..View full abstract
Related Projects (1)
Awarded by National Health & Medical Research Council (NHMRC)
This work was supported by the National Health & Medical Research Council (NHMRC) grant number: APP1141344) funded 2018-2023. The named chief investigator team are: Victoria Palmer, Jane Gunn, Carol Harvey, John Furler, David Osborn, Mahesh Jayaram, Patty Chondros, Sandra Davidson, Amanda Kenny. The Associate Investigator team are: Mark Nelson, David Castle, Vera Morgan, Stephen Harrap.